Cholesterol

in composite trading on the New York Stock Exchange.

They have risen 10 percent this year, giving the company a market value of $5.3 billion.

Shares of Pfizer rose 12 cents to $26.73.

Teva fell 120 shekels to 15,470 ($3,947) in Tel Aviv.

The case is Mylan Laboratories Inc.

v.

Leavitt, 07cv579, U.S.

District Court, District of Columbia (Washington).

To contact the reporters on this story: Susan Decker in Washington at sdecker1@bloomberg.net ; Jeff St.Onge in Washington at jstonge@bloomberg.net .

Last Updated: April 30, 2007 11:27 EDT Email this articlePrinter friendly format More News Bank of Montreal Fails to Control Risks in Canada's Biggest Trading Loss Canadian Economy Grew a More-Than-Expected 0.4 Percent in February on Oil Shoppers Drug Mart First-Quarter Profit Climbs 19 Percent on Expansion NEWS 日本語サイト ...

Read more...